Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Second-line chemotherapy for hormone-refractory prostate cancer: has the time come?

Second-line chemotherapy for hormone-refractory prostate cancer: has the time come? Clin Prostate Cancer. 2004 Sep; 3(2):122-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.